These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


369 related items for PubMed ID: 6352714

  • 1. Stimulation of the proliferation of the Madin-Darby canine kidney (MDCK) epithelial cell line by high-density lipoproteins and their induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.
    Gospodarowicz D, Cohen DC, Massoglia SL.
    J Cell Physiol; 1983 Oct; 117(1):76-90. PubMed ID: 6352714
    [Abstract] [Full Text] [Related]

  • 2. Biotin and choline replace the growth requirement of Madin-Darby canine kidney cells for high-density lipoproteins.
    Cohen DC, Gospodarowicz D.
    J Cell Physiol; 1985 Jul; 124(1):96-106. PubMed ID: 4044653
    [Abstract] [Full Text] [Related]

  • 3. Regulation of sterol synthesis and of 3-hydroxy-3-methylglutaryl coenzyme A reductase by lipoproteins in glial cells in primary culture.
    Langan TJ, Iimori Y, White G, Volpe JJ.
    J Neurosci Res; 1987 Jul; 17(4):361-6. PubMed ID: 2887663
    [Abstract] [Full Text] [Related]

  • 4. Effect of rous sarcoma virus transformation of rat-1 fibroblasts upon their growth factor and anchorage requirements in serum-free medium.
    Giguère L, Gospodarowicz D.
    Cancer Res; 1983 May; 43(5):2121-30. PubMed ID: 6299541
    [Abstract] [Full Text] [Related]

  • 5. Factors involved in supporting the growth and steroidogenic functions of bovine adrenal cortical cells maintained on extracellular matrix and exposed to a serum-free medium.
    Ill CR, Gospodarowicz D.
    J Cell Physiol; 1982 Dec; 113(3):373-84. PubMed ID: 6294125
    [Abstract] [Full Text] [Related]

  • 6. High-density lipoproteins and the proliferation of human tumor cells maintained on extracellular matrix-coated dishes and exposed to defined medium.
    Gospodarowicz D, Lui GM, Gonzalez R.
    Cancer Res; 1982 Sep; 42(9):3704-13. PubMed ID: 7049362
    [Abstract] [Full Text] [Related]

  • 7. Factors involved in the control of proliferation of bovine corneal endothelial cells maintained in serum-free medium.
    Giguère L, Cheng J, Gospodarowicz D.
    J Cell Physiol; 1982 Jan; 110(1):72-80. PubMed ID: 6461663
    [Abstract] [Full Text] [Related]

  • 8. Macrophage 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in sitosterolemia: effects of increased cellular cholesterol and sitosterol concentrations.
    Nguyen LB, Salen G, Shefer S, Tint GS, Ruiz F.
    Metabolism; 2001 Oct; 50(10):1224-9. PubMed ID: 11586498
    [Abstract] [Full Text] [Related]

  • 9. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH, Gotto AM, Jackson RL, Patsch JR, Sybers HD, Taunton OD, Yeshurun DL, Smith LC.
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [Abstract] [Full Text] [Related]

  • 10. Role of lipoproteins and 3-hydroxy-3-methylglutaryl coenzyme A reductase in progesterone production by cultured bovine granulosa cells.
    Savion N, Laherty R, Cohen D, Lui GM, Gospodarowicz D.
    Endocrinology; 1982 Jan; 110(1):13-22. PubMed ID: 6274615
    [Abstract] [Full Text] [Related]

  • 11. Overaccumulation of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase in a compactin(ML-236B)-resistant mouse cell line with defects in the regulation of its activity.
    Hasumi K, Yamada A, Shimizu Y, Endo A.
    Eur J Biochem; 1987 May 04; 164(3):547-52. PubMed ID: 3569277
    [Abstract] [Full Text] [Related]

  • 12. Difference in the ability of compactin and oxidized cholesterol, both known inhibitors of cholesterol biosynthesis, to suppress in vitro immune responses.
    Humphries GM.
    Cancer Res; 1981 Sep 04; 41(9 Pt 2):3789-91. PubMed ID: 7260948
    [Abstract] [Full Text] [Related]

  • 13. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2.
    Cohen LH, Griffioen M, Havekes L, Schouten D, van Hinsbergh V, Kempen HJ.
    Biochem J; 1984 Aug 15; 222(1):35-9. PubMed ID: 6089762
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis.
    Maltese WA, Sheridan KM.
    J Cell Physiol; 1985 Dec 15; 125(3):540-58. PubMed ID: 3851809
    [Abstract] [Full Text] [Related]

  • 15. Requirement for mevalonate in the control of proliferation of human breast cancer cells.
    Wejde J, Blegen H, Larsson O.
    Anticancer Res; 1992 Dec 15; 12(2):317-24. PubMed ID: 1580550
    [Abstract] [Full Text] [Related]

  • 16. Mevalonic acid products as mediators of cell proliferation in simian virus 40-transformed 3T3 cells.
    Larsson O, Johansson BM.
    Cancer Res; 1987 Sep 15; 47(18):4825-9. PubMed ID: 3040232
    [Abstract] [Full Text] [Related]

  • 17. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
    Ness GC, Lopez D, Chambers CM, Zhao Z, Beach DL, Ko SS, Trzaskos JM.
    Arch Biochem Biophys; 1998 Sep 15; 357(2):259-64. PubMed ID: 9735166
    [Abstract] [Full Text] [Related]

  • 18. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
    Straka MS, Panini SR.
    Arch Biochem Biophys; 1995 Feb 20; 317(1):235-43. PubMed ID: 7872789
    [Abstract] [Full Text] [Related]

  • 19. [Regulation of hepatocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase in primary cell cultures through low density lipoproteins].
    Gaertner U.
    Z Gastroenterol; 1978 Apr 20; 16(4):251-6. PubMed ID: 207027
    [Abstract] [Full Text] [Related]

  • 20. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
    Choi JW, Jung SE.
    J Pharmacol Exp Ther; 1999 Apr 20; 289(1):572-9. PubMed ID: 10087052
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.